No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer

byTeddy Guo

November 8, 2021

in StudyGraphics

Reading Time: 1 min read

Hormonal fluctuations in the menstrual cycle may affect sleep and memory performance

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

AI Roundup

Artificial intelligence accelerates drug discovery and reduces animal testing

September 12, 2025

Oncology

Royalty financing deepens exposure to small cell lung cancer revenues

September 8, 2025

Brain lesions on MRI linked with subsequent increased stroke risk

Neurology

Moderate to severe TBI is associated with elevated malignant brain tumor risk

September 1, 2025

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

Weekly Rewinds

2 Minute Medicine Rewind September 1, 2025

September 1, 2025

Adolescents’ muscle strength associated with lower cardiometabolic risk

Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease

$Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest$

Similar clinical outcomes for targeted temperature management at 31C versus 34C in cardiac arrest survivors

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Prescription of tramadol is associated with higher rates of adverse clinical outcomes compared to codeine in patients with chronic, noncancer pain

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports